Evidence map›Paper›PMID 9585419›Full record

ArticleThe Journal of cell biology1998

The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis.

M L Matter, Z Zhang, C Nordstedt, E Ruoslahti

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Molecules (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Going Too Far Is the Same as Falling ShortFrontiers in cellular neuroscience · 2019
    Review
  14. Article
  15. Article
  16. Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

M L MatterLa Jolla Cancer Research Center, The Burnham Institute, La Jolla, California 92037, USA.
Z Zhang
C Nordstedt
E Ruoslahti
Karolinska University Hospital · SECancer Research Center · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
CELL-MATRIX INTERACTIONST32CA009579 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI ENGVALL, EVA S · 1987 to 2001
$306k
THE INFLUENCE OF MATRIX ON THE DIFFERENTIATION OF EMBRYONAL ENDODERMP01CA028896 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI PARELLO, JOSEPH · 1985 to 1997
–
NCI NIH HHS CA09579NCI NIH HHS CA28896NCI NIH HHS CA 30199NCI NIH HHS P30 CA030199NCI NIH HHS T32 CA009579
6 · The paper itself

Abstract

The amyloid-beta peptide (Abeta) can mediate cell attachment by binding to beta1 integrins through an arg-his-asp sequence. We show here that the alpha5beta1 integrin, a fibronectin receptor, is an efficient binder of Abeta, and mediates cell attachment to nonfibrillar Abeta. Cells engineered to express alpha5beta1 internalized and degraded more added Abeta1-40 than did alpha5beta1-negative control cells. Deposition of an insoluble Abeta1-40 matrix around the alpha5beta1-expressing cells was reduced, and the cells showed less apoptosis than the control cells. Thus, the alpha5beta1 integrin may protect against Abeta deposition and toxicity, which is a course of Alzheimer's disease lesions.

Indexed as

Cell AdhesionAmyloid beta-PeptidesAnimalsApoptosisCell LineCell SurvivalCHO CellsCricetinaeFlow CytometryHumansKineticsNeuroblastomaPeptide FragmentsReceptors, FibronectinRecombinant ProteinsTransfectionAmyloid beta-Peptidesamyloid beta-protein (1-40)Peptide FragmentsReceptors, FibronectinRecombinant Proteins

Identifiers

PMID9585419
PMCPMC2132763
OpenAlexW2304471970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.